• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

入住重症监护病房的 COVID-19 患者的临床特征及预后

Clinical Characteristics and Outcomes of COVID-19 Patients Hospitalized in Intensive Care Unit.

作者信息

Pandit Rahul A, Gagana B N, Vaity Charudatt, Mulakavalupil Bindu, Choudhary Jitendra S, Jain Vivek, Chandan Pramila M, Joshi Harsh

机构信息

Department of Critical Care Medicine, Fortis Hospital Mulund, Mumbai, Maharashtra, India.

出版信息

Indian J Crit Care Med. 2021 Sep;25(9):992-1000. doi: 10.5005/jp-journals-10071-23945.

DOI:10.5005/jp-journals-10071-23945
PMID:34963716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8664017/
Abstract

BACKGROUND

Meta-analysis and clinical studies suggest coronavirus disease-2019 (COVID-19) patients in ICU have a high mortality rate of 30-45%, which has evolved as a function of criteria of admission and the management modalities.

MATERIALS AND METHODS

We conducted a retrospective evaluation for characteristics and outcomes in critical care set up across six months.

RESULTS

514 patients (74.3% males and 25.6% females) were evaluated. 9.72% ( = 50) patients expired, 78% ( = 39) were males. Mean age (years) was 57 (±14, range 64, 95% CI 55-58). 65.7% ( = 338) were of age more than 50 years, of which 71.5% ( = 242) were males. Males at 20% higher risk for death than women. (RR = 1.2, 95% CI 0.66-2.31, = 0.61 NS). There was 18% less risk of mortality in female vs male with comorbidities (RR 0.82, 95% CI 0.67-1.12, = 0.32 NS). Risk for mortality in diabetics was significantly increased by 116% vs nondiabetics. (RR 2.16, = 0.0055, 95% CI 1.28-3.67). Highly significant risk of mortality in age group >50 years (3.13 times higher) vs age ≤50 years. (RR 3.18, 95% CI 1.71-8.64, = 0.0003). 50.2% had moderate ARDS at admission. High flow nasal cannula was used in 47.2%. There is 5.79 times more likelihood to be on the ventilator with moderate to severe ARDS vs mild ARDS (RR = 5.79, 95% CI 3.10-11.05, <0.0001). Risk for death was six times higher for patients on ventilator vs not on ventilator (RR = 6.08, 95% CI 3.49-10.59, <0.0001). The mean number of days on ventilator for patients who underwent tracheostomy ( = 49) was 14 days as compared to 6.6 days in patients who were extubated ( = 57) ( <0.0001). P/F ratio had negative correlation with number of days of hospitalisation (Pearson r -0.391, 95% CI -0.46- -0.31, <0.0001). 67% less chances of mortality in patients on steroids (RR = 0.33, 95% CI 0.19-60, = 0.0012). Mean duration of ICU stay (days) was 8 (± 5, range 29, 95% CI 7.5-8.4).

CONCLUSIONS

We observed that a strict adherence to the basic principles of ARDS management resulted in a lower mortality in ICU setting.

HOW TO CITE THIS ARTICLE

Pandit RA, Gagana BN, Vaity C, Mulakavalupil B, Choudhary JS, Jain V, . Clinical Characteristics and Outcomes of COVID-19 Patients Hospitalized in Intensive Care Unit. Indian J Crit Care Med 2021;25(9):992-1000.

摘要

背景

荟萃分析和临床研究表明,入住重症监护病房(ICU)的2019冠状病毒病(COVID-19)患者死亡率较高,为30%-45%,其死亡率会因入院标准和管理方式而有所变化。

材料与方法

我们对六个月内重症监护环境中的患者特征和结局进行了回顾性评估。

结果

共评估了514例患者(男性占74.3%,女性占25.6%)。9.72%(n = 50)的患者死亡,其中78%(n = 39)为男性。平均年龄为57岁(±14,范围64,95%置信区间55-58)。65.7%(n = 338)的患者年龄超过50岁,其中71.5%(n = 242)为男性。男性死亡风险比女性高20%。(风险比率=1.2,95%置信区间0.66-2.31,P = 0.61,无统计学意义)。合并症患者中,女性死亡率比男性低18%(风险比率0.82,95%置信区间0.67-1.12,P = 0.32,无统计学意义)。糖尿病患者的死亡风险比非糖尿病患者显著增加116%。(风险比率2.16,P = 0.0055,95%置信区间1.28-3.67)。年龄>50岁组的死亡风险极高(是≤50岁组的3.13倍)。(风险比率3.18,95%置信区间1.71-8.64,P = 0.0003)。50.2%的患者入院时患有中度急性呼吸窘迫综合征(ARDS)。47.2%的患者使用了高流量鼻导管。与轻度ARDS患者相比,中度至重度ARDS患者使用呼吸机的可能性高5.79倍(风险比率=5.79,95%置信区间3.10-11.05,P<0.0001)。使用呼吸机的患者死亡风险比未使用呼吸机的患者高6倍(风险比率=6.08,95%置信区间3.49-10.59,P<0.0001)。接受气管切开术的患者(n = 49)使用呼吸机的平均天数为14天,而拔管患者(n = 57)为6.6天(P<0.0001)。氧合指数与住院天数呈负相关(皮尔逊相关系数r=-0.391,95%置信区间-0.46--0.31,P<0.0001)。使用类固醇的患者死亡率降低67%(风险比率=0.33,95%置信区间0.19-60,P = 0.0012)。ICU平均住院时间为8天(±5,范围29,95%置信区间7.5-8.4)。

结论

我们观察到,严格遵循ARDS管理的基本原则可降低ICU环境中的死亡率。

如何引用本文

潘迪特·拉杰、加加纳·巴努、瓦蒂·C、穆拉卡瓦卢皮尔·B、乔杜里·J·S、贾恩·V等。入住重症监护病房的COVID-19患者的临床特征和结局。《印度重症监护医学杂志》2021年;25(9):992-1000。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/51bf718e8a35/ijccm-25-992-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/644b5ccd71bf/ijccm-25-992-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/c06a4fa9e6b5/ijccm-25-992-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/58f6e2ce7a78/ijccm-25-992-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/cd2018e41fc8/ijccm-25-992-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/852ebde76745/ijccm-25-992-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/0a64ff73901b/ijccm-25-992-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/207b02f85974/ijccm-25-992-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/bad0b843f5f6/ijccm-25-992-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/51bf718e8a35/ijccm-25-992-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/644b5ccd71bf/ijccm-25-992-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/c06a4fa9e6b5/ijccm-25-992-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/58f6e2ce7a78/ijccm-25-992-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/cd2018e41fc8/ijccm-25-992-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/852ebde76745/ijccm-25-992-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/0a64ff73901b/ijccm-25-992-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/207b02f85974/ijccm-25-992-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/bad0b843f5f6/ijccm-25-992-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d1/8664017/51bf718e8a35/ijccm-25-992-g009.jpg

相似文献

1
Clinical Characteristics and Outcomes of COVID-19 Patients Hospitalized in Intensive Care Unit.入住重症监护病房的 COVID-19 患者的临床特征及预后
Indian J Crit Care Med. 2021 Sep;25(9):992-1000. doi: 10.5005/jp-journals-10071-23945.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS: A Randomized Clinical Trial.低潮气量与中潮气量策略对无急性呼吸窘迫综合征的 ICU 患者呼吸机使用天数的影响:一项随机临床试验。
JAMA. 2018 Nov 13;320(18):1872-1880. doi: 10.1001/jama.2018.14280.
4
Effect of a Lower vs Higher Positive End-Expiratory Pressure Strategy on Ventilator-Free Days in ICU Patients Without ARDS: A Randomized Clinical Trial.低水平 vs 高水平呼气末正压通气策略对无急性呼吸窘迫综合征 ICU 患者呼吸机使用时间的影响:一项随机临床试验。
JAMA. 2020 Dec 22;324(24):2509-2520. doi: 10.1001/jama.2020.23517.
5
Analysis of Predictors and Outcomes of COVID-19 Patients Requiring ICU Admission from COVID-19 Registry, India.印度COVID-19登记处中需要入住重症监护病房的COVID-19患者的预测因素和结局分析。
Indian J Crit Care Med. 2023 Aug;27(8):552-562. doi: 10.5005/jp-journals-10071-24496.
6
[Dynamic measurement of volume of atelectasis area in the evaluation of the prognosis of patients with moderate-to-severe acute respiratory distress syndrome].[动态测量肺不张面积在中重度急性呼吸窘迫综合征患者预后评估中的应用]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Sep;32(9):1056-1060. doi: 10.3760/cma.j.cn121430-20191219-00056.
7
Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.在一个多机构医疗系统中,2019冠状病毒病检测呈阳性的住院患者发生深静脉血栓形成和肺栓塞预示着更高的死亡率以及更长的重症监护病房住院时间和医院住院时间。
J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1361-1370.e1. doi: 10.1016/j.jvsv.2021.03.009. Epub 2021 Apr 6.
8
The Second- vs First-wave COVID-19: More of the Same or a Lot Worse? A Comparison of Mortality between the Two Waves in Patients Admitted to Intensive Care Units in Nine Hospitals in Western Maharashtra.新冠疫情第二波与第一波:情况相同还是更糟?马哈拉施特拉邦西部九家医院重症监护病房收治的两波患者死亡率比较
Indian J Crit Care Med. 2021 Dec;25(12):1343-1348. doi: 10.5005/jp-journals-10071-24042.
9
Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.危重症患者的口腔卫生护理以预防呼吸机相关性肺炎。
Cochrane Database Syst Rev. 2016 Oct 25;10(10):CD008367. doi: 10.1002/14651858.CD008367.pub3.
10
Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.COVID-19 住院患者中的代谢综合征与急性呼吸窘迫综合征。
JAMA Netw Open. 2021 Dec 1;4(12):e2140568. doi: 10.1001/jamanetworkopen.2021.40568.

引用本文的文献

1
Validation of Global Definition of Acute Respiratory Distress Syndrome in COVID-19 Patients: A Retrospective Study.新型冠状病毒肺炎患者急性呼吸窘迫综合征全球定义的验证:一项回顾性研究
Indian J Crit Care Med. 2025 Jul;29(7):556-561. doi: 10.5005/jp-journals-10071-25006. Epub 2025 Jul 7.
2
Evaluation of Predictors, Kinetics of Renal Recovery and Outcomes of COVID-19 Patients with Acute Kidney Injury Admitted to Intensive Care Unit: An Observational Study.重症监护病房收治的COVID-19急性肾损伤患者的预测因素评估、肾脏恢复动力学及预后:一项观察性研究。
Indian J Crit Care Med. 2022 Dec;26(12):1293-1299. doi: 10.5005/jp-journals-10071-24372.
3

本文引用的文献

1
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline.成人 2019 冠状病毒病(COVID-19)住院患者管理:欧洲呼吸学会临床实践指南。
Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00048-2021. Print 2021 Apr.
2
Efficacy of corticosteroid in patients with COVID-19: A multi-center retrospective study and meta-analysis.COVID-19 患者中皮质类固醇的疗效:一项多中心回顾性研究和荟萃分析。
J Med Virol. 2021 Jul;93(7):4292-4302. doi: 10.1002/jmv.26914. Epub 2021 May 5.
3
Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis.
Air leak in post COVID-19 patients: Incidence, ICU course and outcomes.
新冠后患者的空气泄漏:发病率、重症监护病房病程及结局
Med Intensiva (Engl Ed). 2022 Nov;46(11):648-650. doi: 10.1016/j.medine.2021.12.019.
4
Clinical Profile of Patients Presenting With Sepsis to the Emergency Department of a Tertiary Care Hospital in Wardha During the COVID Pandemic (June 2020-June 2021).2020年6月至2021年6月新冠疫情期间,瓦尔达一家三级护理医院急诊科收治的脓毒症患者临床概况
Cureus. 2022 Sep 24;14(9):e29528. doi: 10.7759/cureus.29528. eCollection 2022 Sep.
5
COVID-19 and the cardiovascular system: an update.新型冠状病毒肺炎与心血管系统:最新进展。
Am J Med Sci. 2022 Aug;364(2):139-147. doi: 10.1016/j.amjms.2022.01.022. Epub 2022 Feb 11.
6
Air leak in post COVID-19 patients: Incidence, ICU course and outcomes.新冠后患者的空气泄漏:发病率、重症监护病房病程及结局
Med Intensiva. 2022 Nov;46(11):648-650. doi: 10.1016/j.medin.2021.12.012. Epub 2022 Jan 7.
7
Critical Illness in COVID-19: A Sobering Experience for the Intensivist.新型冠状病毒肺炎危重症:重症监护医生的沉痛经历
Indian J Crit Care Med. 2021 Sep;25(9):965-966. doi: 10.5005/jp-journals-10071-23983.
COVID-19 中类固醇治疗的疗效和安全性:快速系统评价和 Meta 分析。
Indian J Pharmacol. 2020 Nov-Dec;52(6):535-550. doi: 10.4103/ijp.ijp_1146_20.
4
COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis.COVID-19 住院患者病死率:系统评价和荟萃分析。
Ann Epidemiol. 2021 May;57:14-21. doi: 10.1016/j.annepidem.2021.02.012. Epub 2021 Mar 2.
5
Early Prone Positioning and Non-Invasive Ventilation in a Critical COVID-19 Subset. A Single Centre Experience in Southern Italy.重症新型冠状病毒肺炎患者的早期俯卧位通气与无创通气:意大利南部单中心经验
Turk Thorac J. 2021 Jan;22(1):57-61. doi: 10.5152/TurkThoracJ.2021.20158. Epub 2021 Jan 1.
6
Mechanisms of Hypoxia in COVID-19 Patients: A Pathophysiologic Reflection.新冠病毒肺炎患者的缺氧机制:病理生理学思考
Indian J Crit Care Med. 2020 Oct;24(10):967-970. doi: 10.5005/jp-journals-10071-23547.
7
Coronavirus disease 2019 in chronic kidney disease.2019冠状病毒病与慢性肾脏病
Clin Kidney J. 2020 Jul 16;13(3):297-306. doi: 10.1093/ckj/sfaa104. eCollection 2020 Jun.
8
Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis.新冠肺炎患者入住重症监护病房的比例和结局:一项系统评价和 Meta 分析。
PLoS One. 2020 Jul 10;15(7):e0235653. doi: 10.1371/journal.pone.0235653. eCollection 2020.
9
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?血管紧张素转化酶抑制剂是否应该用于高血压的治疗?
Curr Cardiol Rep. 2020 Jul 9;22(9):95. doi: 10.1007/s11886-020-01352-8.
10
Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study.慢性阻塞性肺疾病患者新型冠状病毒肺炎感染的临床特征:一项多中心、回顾性、观察性研究
J Thorac Dis. 2020 May;12(5):1811-1823. doi: 10.21037/jtd-20-1914.